Hence, cancers with MGMT methylation (m-MGMT) tend to be highly responsive to TMZ with an increase in median survival of approximately six and one-half months compared to less than one month for unmethylated-MGMT (u-MGMT) cancers [2]. This evidence concerns the gene MGMT and cancer.